tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksFDA CalendarMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsGlossaryFAQs
About Us
About TipRanksContact UsReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Private Companies
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

TBPH Stock Latest News

Theravance Biopharma: Asymmetric Upside from Ampreloxetine on Top of a Cash-Flow-Positive Base Business Supports Buy Rating
RatingsTheravance Biopharma: Asymmetric Upside from Ampreloxetine on Top of a Cash-Flow-Positive Base Business Supports Buy Rating
11d ago
TBPH
Theravance Biopharma management to meet with B. Riley
PremiumThe Fly
Theravance Biopharma management to meet with B. Riley
22d ago
TBPH
Theravance Biopharma highlights cash-generation, YUPELRI growth, ampreloxetine
PremiumCompany Announcements
Theravance Biopharma highlights cash-generation, YUPELRI growth, ampreloxetine
1M ago
8K
TBPH
Theravance Biopharma’s Ampreloxetine: A Promising Candidate for Neurogenic Orthostatic Hypotension with Strong Market Potential
PremiumRatings
Theravance Biopharma’s Ampreloxetine: A Promising Candidate for Neurogenic Orthostatic Hypotension with Strong Market Potential
2M ago
TBPH
Theravance Biopharma’s Ampreloxetine: A Promising Solution for MSA with Strategic Market Positioning
PremiumRatings
Theravance Biopharma’s Ampreloxetine: A Promising Solution for MSA with Strategic Market Positioning
2M ago
TBPH
Theravance Biopharma’s Ampreloxetine: A Promising Treatment for Neurogenic Orthostatic Hypotension with Strong Commercial Prospects
PremiumRatingsTheravance Biopharma’s Ampreloxetine: A Promising Treatment for Neurogenic Orthostatic Hypotension with Strong Commercial Prospects
2M ago
TBPH
Theravance Biopharma Hosts Key Opinion Leader Event
Premium
Company Announcements
Theravance Biopharma Hosts Key Opinion Leader Event
2M ago
8K
TBPH
Theravance Biopharma initiated with an Outperform at Oppenheimer
Premium
The Fly
Theravance Biopharma initiated with an Outperform at Oppenheimer
2M ago
TBPH
These 3 Stocks Could Explode Higher, Say Five-Star Analysts – 11/28/2025
PremiumMarket News
These 3 Stocks Could Explode Higher, Say Five-Star Analysts – 11/28/2025
3M ago
GPCR
TBPH
Theravance Biopharma price target raised to $40 from $25 at BTIG
PremiumThe Fly
Theravance Biopharma price target raised to $40 from $25 at BTIG
3M ago
TBPH
Theravance Biopharma management to meet virtually with BTIG
PremiumThe Fly
Theravance Biopharma management to meet virtually with BTIG
3M ago
TBPH
Theravance Biopharma’s Earnings Call Highlights Robust Growth
PremiumCompany Announcements
Theravance Biopharma’s Earnings Call Highlights Robust Growth
3M ago
TBPH
Theravance Biopharma price target raised to $20 from $15 at H.C. Wainwright
PremiumThe FlyTheravance Biopharma price target raised to $20 from $15 at H.C. Wainwright
3M ago
TBPH
Theravance Biopharma: Hold Rating Amid Steady Growth and Pipeline Uncertainty
Premium
Ratings
Theravance Biopharma: Hold Rating Amid Steady Growth and Pipeline Uncertainty
3M ago
TBPH
Theravance Biopharma Reports Strong Q3 2025 Results
Premium
Company Announcements
Theravance Biopharma Reports Strong Q3 2025 Results
3M ago
TBPH
Theravance Biopharma reports Q3 EPS 7c, consensus (5c)
PremiumThe Fly
Theravance Biopharma reports Q3 EPS 7c, consensus (5c)
3M ago
TBPH
TBPH Upcoming Earnings Report: What to Expect?
PremiumPre-Earnings
TBPH Upcoming Earnings Report: What to Expect?
3M ago
TBPH
Theravance Biopharma initiated with a Buy at B. Riley
PremiumThe Fly
Theravance Biopharma initiated with a Buy at B. Riley
5M ago
TBPH
Promising Outlook for Theravance Biopharma: Buy Rating Backed by Phase 3 CYPRESS Trial Developments
PremiumRatings
Promising Outlook for Theravance Biopharma: Buy Rating Backed by Phase 3 CYPRESS Trial Developments
6M ago
TBPH
Theravance Completes Enrollment in Phase 3 CYPRESS Study
PremiumCompany AnnouncementsTheravance Completes Enrollment in Phase 3 CYPRESS Study
6M ago
8K
TBPH
Theravance Biopharma completes enrollment in CYPRESS study
Premium
The Fly
Theravance Biopharma completes enrollment in CYPRESS study
6M ago
TBPH
Theravance Biopharma Settles Patent Dispute with Cipla
Premium
Company Announcements
Theravance Biopharma Settles Patent Dispute with Cipla
6M ago
8K
TBPH

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >